Cargando…
Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
OBJECTIVES: The aim of the present study was to evaluate the clinical relevance of mutations in tumor suppressor genes using whole-exome sequencing data from centenarians and young healthy individuals. METHODS: Two pools, one of centenarians and one of young individuals, were constructed and whole-e...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132786/ https://www.ncbi.nlm.nih.gov/pubmed/32233832 http://dx.doi.org/10.1177/1533033820911082 |
_version_ | 1783517505266909184 |
---|---|
author | Balabanski, Lubomir Serbezov, Dimitar Nikolova, Dragomira Antonova, Olga Nesheva, Desislava Hammoudeh, Zora Vazharova, Radoslava Karachanak-Yankova, Sena Staneva, Rada Mihaylova, Marta Damyanova, Vera Hadjidekova, Savina Toncheva, Draga |
author_facet | Balabanski, Lubomir Serbezov, Dimitar Nikolova, Dragomira Antonova, Olga Nesheva, Desislava Hammoudeh, Zora Vazharova, Radoslava Karachanak-Yankova, Sena Staneva, Rada Mihaylova, Marta Damyanova, Vera Hadjidekova, Savina Toncheva, Draga |
author_sort | Balabanski, Lubomir |
collection | PubMed |
description | OBJECTIVES: The aim of the present study was to evaluate the clinical relevance of mutations in tumor suppressor genes using whole-exome sequencing data from centenarians and young healthy individuals. METHODS: Two pools, one of centenarians and one of young individuals, were constructed and whole-exome sequencing was performed. We examined the whole-exome sequencing data of Bulgarian individuals for carriership of tumor suppressor gene variants. RESULTS: Of all variants annotated in both pools, 5080 (0.06%) are variants in tumor suppressor genes but only 46 show significant difference in allele frequencies between the two studied groups. Four variants (0.004%) are pathogenic/risk factors according to single nucleotide polymorphism database: rs1566734 in PTPRJ, rs861539 in XRCC3, rs203462 in AKAP10, and rs486907 in RNASEL. DISCUSSION: Based on their high minor allele frequencies and presence in the centenarian group, we could reclassify them from pathogenic/risk factors to benign. Our study shows that centenarian exomes can be used for re-evaluating the clinically uncertain variants. |
format | Online Article Text |
id | pubmed-7132786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-71327862020-04-13 Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations Balabanski, Lubomir Serbezov, Dimitar Nikolova, Dragomira Antonova, Olga Nesheva, Desislava Hammoudeh, Zora Vazharova, Radoslava Karachanak-Yankova, Sena Staneva, Rada Mihaylova, Marta Damyanova, Vera Hadjidekova, Savina Toncheva, Draga Technol Cancer Res Treat Original Article OBJECTIVES: The aim of the present study was to evaluate the clinical relevance of mutations in tumor suppressor genes using whole-exome sequencing data from centenarians and young healthy individuals. METHODS: Two pools, one of centenarians and one of young individuals, were constructed and whole-exome sequencing was performed. We examined the whole-exome sequencing data of Bulgarian individuals for carriership of tumor suppressor gene variants. RESULTS: Of all variants annotated in both pools, 5080 (0.06%) are variants in tumor suppressor genes but only 46 show significant difference in allele frequencies between the two studied groups. Four variants (0.004%) are pathogenic/risk factors according to single nucleotide polymorphism database: rs1566734 in PTPRJ, rs861539 in XRCC3, rs203462 in AKAP10, and rs486907 in RNASEL. DISCUSSION: Based on their high minor allele frequencies and presence in the centenarian group, we could reclassify them from pathogenic/risk factors to benign. Our study shows that centenarian exomes can be used for re-evaluating the clinically uncertain variants. SAGE Publications 2020-04-01 /pmc/articles/PMC7132786/ /pubmed/32233832 http://dx.doi.org/10.1177/1533033820911082 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Balabanski, Lubomir Serbezov, Dimitar Nikolova, Dragomira Antonova, Olga Nesheva, Desislava Hammoudeh, Zora Vazharova, Radoslava Karachanak-Yankova, Sena Staneva, Rada Mihaylova, Marta Damyanova, Vera Hadjidekova, Savina Toncheva, Draga Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations |
title | Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of
Germline Tumor Suppressor Mutations |
title_full | Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of
Germline Tumor Suppressor Mutations |
title_fullStr | Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of
Germline Tumor Suppressor Mutations |
title_full_unstemmed | Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of
Germline Tumor Suppressor Mutations |
title_short | Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of
Germline Tumor Suppressor Mutations |
title_sort | centenarian exomes as a tool for evaluating the clinical relevance of
germline tumor suppressor mutations |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132786/ https://www.ncbi.nlm.nih.gov/pubmed/32233832 http://dx.doi.org/10.1177/1533033820911082 |
work_keys_str_mv | AT balabanskilubomir centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT serbezovdimitar centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT nikolovadragomira centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT antonovaolga centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT neshevadesislava centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT hammoudehzora centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT vazharovaradoslava centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT karachanakyankovasena centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT stanevarada centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT mihaylovamarta centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT damyanovavera centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT hadjidekovasavina centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations AT tonchevadraga centenarianexomesasatoolforevaluatingtheclinicalrelevanceofgermlinetumorsuppressormutations |